RK
RHÖN-KLINIKUM Aktiengesellschaft
RKAGY · OTC
$8.16 +0.00% (+$0.00)
Market Cap 952.7M €
P/E Ratio 22.58x
Div. Yield 1.44%
ROE 3.19%
Bulios Fair Price
$11.52
41.2% upside
Current Price
$8.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RKAGY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
82 /100
Cheap P/S 0.52x
P/E 22.58x
P/B 0.72x
Growth
57 /100
Stable Book val. growth 2.56%
EPS growth 9.58%
Rev. growth 8.74%
Profitability
10 /100
Weak Op. margin 2.84%
Gross margin 3.10%
FCF margin 0.00%
Quality
24 /100
Poor ROA 2.31%
ROIC 2.79%
Asset turnover 1.00x
Debt
100 /100
Low Int. coverage 18.16x
Debt/Equity 0.09x
Net debt/EBITDA -0.09x
Stability
60 /100
Moderate EPS volatility 39.62%
Beta 0.07x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RKAGY
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Tobias Kaltenbach
Employees
19,128
Headquarters
Bad Neustadt an der Saale
Upcoming events
05 NOV
Earnings
Upcoming earnings report